Skip to contentM
Minerva Neurosciences, Inc.
M
NERVMinerva Neurosciences, Inc. Released Aug 7, 2014, after the close
10-Q filed Aug 7, 2014, 38 days after period end · 0001104659-14-058266
Q2 2014 · 10-Q
Revenue—
Net Income-$19.37M-$19.37MN/M vs Q2 2013N/M vs Q1 2014 EPS Diluted-$2.55-$2.55
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Minerva Neurosciences, Inc. · CIK 1598646 · Engraved from SEC EDGAR
N/M vs Q1 2014
Operating Income-$17,650,000N/M Operating Cash Flowderived-$2,544,039— ended Jun 30, 2014 · filed Aug 7, 2014 · 38 d after period end
7.0% from the close of Aug 7, 2014 to the close of Aug 8, 2014, the first after the release.
after the close$7.00$6.51 Jul 10Aug 7Sep 11